Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

3M (European pharmaceutical division)

M&A STATUS
301-400 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Distributor of pharmaceutical products. The company's pharmaceutical products are utilized for prevention and remedy of skin diseases, cardiac arrhythmia and angina pectoris, enabling clients to avail quality pharmaceutical products.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • Building 220-11W-02
  • 3M Center
  • Saint Paul, MN 55144
  • United States

3M (European pharmaceutical division) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore 3M (European pharmaceutical division)‘s full profile, request access.

Request full access to PitchBook

3M (European pharmaceutical division) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore 3M (European pharmaceutical division)‘s full profile, request access.

Request full access to PitchBook